Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Metastatic or Advanced Breast Cancer
NCT00054145Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jun 2003
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perifosine in breast cancer, sponsored by University Health Network. Primary endpoint: Objective Tumor Response Rate. Started Jun 2003; status: completed.
02
Drugs
perifosine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00054145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054145.